NCT07118592View on ClinicalTrials.gov

Genetic Architecture of Natriuretic Peptides and Blood Pressure Response

NANot yet recruitingINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

January 1, 2026

Primary Completion Date

June 1, 2030

Study Completion Date

December 1, 2030

Conditions
Hypertension (HTN)Cardiometabolic Diseases
Interventions
DIETARY_SUPPLEMENT

Low Salt Diet

8 days of diet with low salt content will be given to the study participants

DIETARY_SUPPLEMENT

High Salt Diet

8 days of diet with high salt content will be given to the study participants

DIETARY_SUPPLEMENT

Saline Infusion

2 Liters of normal saline infusion (0.25 ml/kg/min over 2 hours) will be given to the study participants at the end of each study period

Trial Locations (1)

35294

University of Alabama at Birmingham, Birmingham

All Listed Sponsors
lead

University of Alabama at Birmingham

OTHER

NCT07118592 - Genetic Architecture of Natriuretic Peptides and Blood Pressure Response | Biotech Hunter | Biotech Hunter